Mi-Heon Lee

Phase I Trial of Intratumoral Injection of<i>CCL21</i>Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration

Jay M. Lee, Mi-Heon Lee, Edward B. Garon et al. · Clinical Cancer Research · 2017 · 224 citations · Full text

Medicine, Immunology, Oncology +17

All-<i>trans</i>Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon-γ–Producing T-cells Without Affecting Th17 Cells

Yang-Hau Van, Wen‐Hwa Lee, Serina Ortiz et al. · Diabetes · 2008 · 114 citations · Full text

Life Sciences, Endocrinology, Immunology +17

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Puja Kachroo, Mi-Heon Lee, Ling Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2013 · 81 citations · Full text

Medicine, Cancer Biology, Oncology +17

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy

Jean Philippe Nesseler, Mi-Heon Lee, Christine Nguyen et al. · Cancers · 2020 · 30 citations · Full text

Medicine, Immunology, Oncology +17

FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.

Mi-Heon Lee, Jane Yanagawa, Linh M. Tran et al. · PubMed · 2020 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +14